Delaware | 26-0237871 |
(State of incorporation) | (I.R.S. Employer Identification No.) |
Page | |
Description | |
the Company, we, us, our | VWR Corporation and its consolidated subsidiaries |
Adjusted EPS* | our net income, adjusted for certain items, divided by diluted weighted average shares outstanding |
Americas | a reportable segment covering North, Central and South America |
Annual Report | our Annual Report on Form 10-K filed with the SEC on February 25, 2016 |
A/R Facility | an accounts receivable securitization facility due 2018 |
Biopharma | the combination of the pharmaceutical and biotechnology sectors |
Board | the board of directors of VWR Corporation |
EMEA-APAC | a reportable segment covering Europe, Middle East, Africa and Asia-Pacific |
GAAP | United States generally accepted accounting principles |
ITRA | the income tax receivable agreement with Varietal |
Organic net sales growth* | the reported growth in net sales compared to a prior period, adjusted by the impact of changes in foreign currency rates and the contribution of acquisitions to the extent not present in the prior reported results |
SEC | the United States Securities and Exchange Commission |
SG&A expenses | selling, general and administrative expenses |
Varietal | Varietal Distribution Holdings, LLC |
* | Denotes a non-GAAP financial measurement. See Part I, Item 2 — “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Key Indicators of Performance and Financial Condition” for more information, including where to find reconciliations from the most directly comparable GAAP-based financial measurements. |
• | unfavorable political, economic, capital and credit market conditions in the regions where we operate; |
• | changes in our customers’ research, development and production and other scientific endeavors; |
• | changes to the life science industry adversely affecting our business; |
• | increased competition from other companies in our industry and our ability to increase our market shares in the geographic regions where we operate; |
• | our ability to maintain relationships with our customers and suppliers; |
• | our ability to consummate and integrate recent and future acquisitions; |
• | the international scope of our operations; |
• | the need to record impairment charges against our goodwill, other intangible and/or other long-lived assets; |
• | existing and increased government regulations to which we and our suppliers are subject; |
• | our ability to comply with applicable antitrust or competition laws; |
• | increased costs to comply with environmental, health and safety laws and regulations; |
• | product liability and other claims in the ordinary course of business; |
• | our ability to hire, train and retain executive officers and other key personnel; |
• | significant interruptions in the operations of our distribution centers or the operations of our suppliers; |
• | failure of our information services and its connectivity to our customers, suppliers and/or certain service providers; |
• | our failure to register and in some cases own the existing applications and registrations for our material trademarks or service marks in certain countries where we do business; |
• | foreign currency exchange rate fluctuations; and |
• | unanticipated increases to our income tax liabilities. |
Item 1. | Financial Statements |
March 31, 2016 | December 31, 2015 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 129.7 | $ | 136.3 | |||
Trade accounts receivable, net of reserves of $10.8 and $12.0 | 640.5 | 583.2 | |||||
Other receivables | 43.3 | 56.6 | |||||
Inventories | 450.4 | 424.0 | |||||
Other current assets | 42.8 | 32.9 | |||||
Total current assets | 1,306.7 | 1,233.0 | |||||
Property and equipment, net | 236.8 | 228.2 | |||||
Goodwill | 1,846.5 | 1,791.4 | |||||
Other intangible assets, net | 1,477.3 | 1,455.6 | |||||
Other assets | 89.7 | 85.6 | |||||
Total assets | $ | 4,957.0 | $ | 4,793.8 | |||
Liabilities, Redeemable Equity and Stockholders’ Equity | |||||||
Current liabilities: | |||||||
Current portion of debt | $ | 173.6 | $ | 92.8 | |||
Accounts payable | 494.3 | 474.5 | |||||
Employee-related liabilities | 70.4 | 61.4 | |||||
Current amount due to Varietal — ITRA | 33.2 | 78.1 | |||||
Other current liabilities | 132.6 | 112.3 | |||||
Total current liabilities | 904.1 | 819.1 | |||||
Debt, net of current portion | 1,934.5 | 1,896.2 | |||||
Amount due to Varietal — ITRA, net of current portion | 51.8 | 85.0 | |||||
Deferred income tax liabilities | 456.5 | 459.5 | |||||
Other liabilities | 151.6 | 158.8 | |||||
Total liabilities | 3,498.5 | 3,418.6 | |||||
Commitments and contingencies (Note 7) | |||||||
Redeemable equity, at redemption value | 39.5 | 38.8 | |||||
Stockholders’ equity: | |||||||
Preferred stock, $0.01 par value; 50.0 shares authorized, no shares issued and outstanding | — | — | |||||
Common stock, $0.01 par value; 750.0 shares authorized, 131.4 shares issued and outstanding | 1.3 | 1.3 | |||||
Additional paid-in capital | 1,735.8 | 1,735.1 | |||||
Retained earnings | 45.1 | 6.3 | |||||
Accumulated other comprehensive loss | (363.2 | ) | (406.3 | ) | |||
Total stockholders’ equity | 1,419.0 | 1,336.4 | |||||
Total liabilities, redeemable equity and stockholders’ equity | $ | 4,957.0 | $ | 4,793.8 |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Net sales | $ | 1,098.3 | $ | 1,029.6 | |||
Cost of goods sold | 787.7 | 738.4 | |||||
Gross profit | 310.6 | 291.2 | |||||
Selling, general and administrative expenses | 230.9 | 217.4 | |||||
Operating income | 79.7 | 73.8 | |||||
Interest expense | (19.2 | ) | (27.2 | ) | |||
Other income (expense), net | (0.6 | ) | 70.3 | ||||
Loss on extinguishment of debt | — | (1.8 | ) | ||||
Income before income taxes | 59.9 | 115.1 | |||||
Income tax provision | (21.1 | ) | (43.6 | ) | |||
Net income | $ | 38.8 | $ | 71.5 | |||
Earnings per share: | |||||||
Basic | $ | 0.30 | $ | 0.54 | |||
Diluted | 0.29 | 0.54 | |||||
Weighted average shares outstanding: | |||||||
Basic | 131.4 | 131.4 | |||||
Diluted | 131.6 | 131.9 |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Net income | $ | 38.8 | $ | 71.5 | |||
Other comprehensive income (loss), net of income taxes: | |||||||
Foreign currency translation: | |||||||
Net unrealized gain (loss) arising during the period | 44.2 | (166.0 | ) | ||||
Derivative instruments: | |||||||
Net unrealized (loss) gain arising during the period | (0.8 | ) | 0.1 | ||||
Reclassification of net gain into earnings | (0.9 | ) | — | ||||
Defined benefit plans: | |||||||
Reclassification of net loss into earnings | 0.6 | 0.7 | |||||
Other comprehensive income (loss) | 43.1 | (165.2 | ) | ||||
Comprehensive income (loss) | $ | 81.9 | $ | (93.7 | ) |
Redeemable equity, at redemption value | Stockholders’ equity | |||||||||||||||||||||||||
Common stock | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss | Total | ||||||||||||||||||||||
Shares | Par value | |||||||||||||||||||||||||
Balance at December 31, 2015 | $ | 38.8 | 131.4 | $ | 1.3 | $ | 1,735.1 | $ | 6.3 | $ | (406.3 | ) | $ | 1,336.4 | ||||||||||||
Share-based compensation expense | — | — | — | 1.4 | — | — | 1.4 | |||||||||||||||||||
Reclassifications to state redeemable equity at redemption value | 0.7 | — | — | (0.7 | ) | — | — | (0.7 | ) | |||||||||||||||||
Net income | — | — | — | — | 38.8 | — | 38.8 | |||||||||||||||||||
Other comprehensive income | — | — | — | — | — | 43.1 | 43.1 | |||||||||||||||||||
Balance at March 31, 2016 | $ | 39.5 | 131.4 | $ | 1.3 | $ | 1,735.8 | $ | 45.1 | $ | (363.2 | ) | $ | 1,419.0 |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 38.8 | $ | 71.5 | |||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||||
Depreciation and amortization | 30.8 | 30.5 | |||||
Net foreign currency remeasurement loss (gain) | 2.4 | (69.3 | ) | ||||
Deferred income tax provision | 8.9 | 31.5 | |||||
Loss on extinguishment of debt | — | 1.8 | |||||
Share-based compensation expense | 1.4 | 1.1 | |||||
Amortization of debt issuance costs | 0.8 | 1.4 | |||||
Other, net | 0.4 | 2.1 | |||||
Changes in working capital, net of business acquisitions: | |||||||
Trade accounts receivable | (32.4 | ) | (38.1 | ) | |||
Inventories | (12.4 | ) | (1.4 | ) | |||
Accounts payable | 6.9 | (14.7 | ) | ||||
Other assets and liabilities | (3.6 | ) | (26.3 | ) | |||
Net cash provided by (used in) operating activities | 42.0 | (9.9 | ) | ||||
Cash flows from investing activities: | |||||||
Acquisitions of businesses, net of cash acquired | (28.9 | ) | (15.6 | ) | |||
Capital expenditures | (14.3 | ) | (9.5 | ) | |||
Other investing activities | — | 0.2 | |||||
Net cash used in investing activities | (43.2 | ) | (24.9 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from debt | 242.1 | 968.4 | |||||
Repayment of debt | (175.4 | ) | (932.2 | ) | |||
Payment to Varietal under ITRA | (78.1 | ) | (9.8 | ) | |||
Payment of debt issuance costs | — | (4.5 | ) | ||||
Other financing activities | 1.1 | 1.9 | |||||
Net cash (used in) provided by financing activities | (10.3 | ) | 23.8 | ||||
Effect of exchange rate changes on cash | 4.9 | (8.5 | ) | ||||
Net decrease in cash and cash equivalents | (6.6 | ) | (19.5 | ) | |||
Cash and cash equivalents at beginning of period | 136.3 | 118.0 | |||||
Cash and cash equivalents at end of period | $ | 129.7 | $ | 98.5 | |||
Supplemental disclosures of cash flow information: | |||||||
Cash paid for interest | $ | 15.0 | $ | 38.2 | |||
Cash paid for income taxes, net | 10.3 | 7.3 |
(1) | Nature of Operations and Basis of Presentation |
• | Varietal Distribution Holdings, LLC (“Varietal”) — Following a 2007 merger, Varietal was our only stockholder until our initial public offering in October 2014 (“IPO”) and since then had been our majority stockholder through March 2016. Private equity funds managed by Madison Dearborn Partners hold a controlling interest in Varietal. Our condensed consolidated balance sheets reflect significant amounts of goodwill and other intangible assets as a result of the 2007 merger. |
• | VWR Funding, Inc. and its wholly-owned subsidiaries (“VWR Funding”) — VWR Funding is our wholly-owned subsidiary and the sole issuer of our debt. Certain of those debt agreements restrict VWR Funding’s ability to make distributions to us. |
(2) | New Accounting Standards |
(3) | Earnings per Share |
Three months ended March 31, | |||||
2016 | 2015 | ||||
Weighted average shares outstanding, basic | 131.4 | 131.4 | |||
Dilutive effect of share-based instruments | 0.2 | 0.5 | |||
Weighted average shares outstanding, diluted | 131.6 | 131.9 |
(4) | Goodwill and Other Intangible Assets, net |
Americas | EMEA-APAC | Total | |||||||||
Balance at December 31, 2015 | $ | 1,046.3 | $ | 745.1 | $ | 1,791.4 | |||||
Acquisitions | 16.7 | 0.1 | 16.8 | ||||||||
Currency translation | 5.3 | 33.0 | 38.3 | ||||||||
Balance at March 31, 2016 | $ | 1,068.3 | $ | 778.2 | $ | 1,846.5 |
March 31, 2016 | December 31, 2015 | ||||||||||||||||||||||
Gross carrying amount | Accumulated impairment losses | Net carrying amount | Gross carrying amount | Accumulated impairment losses | Net carrying amount | ||||||||||||||||||
Americas | $ | 1,274.9 | $ | 206.6 | $ | 1,068.3 | $ | 1,252.9 | $ | 206.6 | $ | 1,046.3 | |||||||||||
EMEA-APAC | 778.2 | — | 778.2 | 745.1 | — | 745.1 | |||||||||||||||||
Total | $ | 2,053.1 | $ | 206.6 | $ | 1,846.5 | $ | 1,998.0 | $ | 206.6 | $ | 1,791.4 |
March 31, 2016 | December 31, 2015 | ||||||||||||||||||||||
Gross carrying amount | Accumulated amortization | Net carrying amount | Gross carrying amount | Accumulated amortization | Net carrying amount | ||||||||||||||||||
Amortizable intangible assets: | |||||||||||||||||||||||
Customer relationships | $ | 1,439.3 | $ | 611.8 | $ | 827.5 | $ | 1,402.2 | $ | 581.4 | $ | 820.8 | |||||||||||
Other | 34.6 | 17.8 | 16.8 | 30.3 | 15.2 | 15.1 | |||||||||||||||||
Total | 1,473.9 | 629.6 | 844.3 | 1,432.5 | 596.6 | 835.9 | |||||||||||||||||
Indefinite-lived intangible assets: | |||||||||||||||||||||||
Trademarks and tradenames | 633.0 | — | 633.0 | 619.7 | — | 619.7 | |||||||||||||||||
Other intangible assets | $ | 2,106.9 | $ | 629.6 | $ | 1,477.3 | $ | 2,052.2 | $ | 596.6 | $ | 1,455.6 |
(5) | Debt |
March 31, 2016 | December 31, 2015 | |||||||||||
Interest terms | Rate | Amount | ||||||||||
Accounts receivable securitization facility | LIBOR plus 1.15% | 1.58 | % | $ | 118.2 | $ | 38.0 | |||||
Senior credit facility: | ||||||||||||
Term A loan, net of discount of $5.8 and $6.1 | LIBOR plus 2.00% | 2.70 | % | 892.8 | 903.9 | |||||||
Term B loan, net of discount of $4.6 and $4.7 | EURIBOR plus 3.25% | 4.00 | % | 517.9 | 494.8 | |||||||
4.625% senior notes, net of discount of $8.3 and $8.4 | Fixed rate | 4.63 | % | 565.3 | 538.6 | |||||||
Other debt | 13.9 | 13.7 | ||||||||||
Total debt | $ | 2,108.1 | $ | 1,989.0 | ||||||||
Classification on consolidated balance sheets: | ||||||||||||
Current portion of debt | $ | 173.6 | $ | 92.8 | ||||||||
Debt, net of current portion | 1,934.5 | 1,896.2 | ||||||||||
Total debt | $ | 2,108.1 | $ | 1,989.0 |
Accounts receivable securitization facility | Multi-currency revolving loan facility | Total | |||||||||
Maximum availability | $ | 175.0 | $ | 250.0 | $ | 425.0 | |||||
Current availability | $ | 167.6 | $ | 250.0 | $ | 417.6 | |||||
Undrawn letters of credit outstanding | (11.4 | ) | (12.1 | ) | (23.5 | ) | |||||
Outstanding borrowings | (118.2 | ) | — | (118.2 | ) | ||||||
Unused availability | $ | 38.0 | $ | 237.9 | $ | 275.9 |
(6) | Financial Instruments and Fair Value Measurements |
March 31, 2016 | December 31, 2015 | ||||||||||||||
Carrying amount | Fair value | Carrying amount | Fair value | ||||||||||||
Accounts receivable securitization facility | $ | 118.2 | $ | 118.2 | $ | 38.0 | $ | 38.0 | |||||||
Senior credit facility: | |||||||||||||||
Term A loan | 892.8 | 895.3 | 903.9 | 901.5 | |||||||||||
Term B loan | 517.9 | 521.5 | 494.8 | 500.5 | |||||||||||
4.625% senior notes | 565.3 | 572.0 | 538.6 | 536.5 | |||||||||||
Other debt | 13.9 | 13.9 | 13.7 | 13.7 |
Three months ended March 31, 2016 | |||
Beginning balance | $ | 21.0 | |
Acquisitions | 7.5 | ||
Loss from changes to estimated fair value | 0.2 | ||
Settlements in cash | (1.8 | ) | |
Currency translation | (0.2 | ) | |
Ending balance | $ | 26.7 |
• | Variable interest rate hedging — Beginning in April 2016, we hedge the variable base interest rate of a portion of our term A loan using interest rate swaps; |
• | Net investment hedging — We hedge a portion of our net investment in euro-denominated foreign operations using our 4.625% senior notes and a portion of our term B loan; |
• | Economic hedge — We experience opposite foreign currency exchange rate effects related to a euro-denominated intercompany loan and the unhedged portion of our term B loan. The currency effects for these non-derivative instruments are recorded through earnings in the period of change and substantially offset one another; and |
• | Other hedging activities — Some of our subsidiaries hedge short-term foreign-denominated business transactions and intercompany financing transactions using foreign currency forward contracts. These activities were not material to our consolidated financial statements. |
Type of hedging relationship | Balance sheet classification | March 31, 2016 | December 31, 2015 | ||||||
€370.0 of term B loan | Net investment | Debt, net of current portion | 419.5 | 402.6 | |||||
€503.8 of 4.625% senior notes | Net investment | Debt, net of current portion | 572.0 | 536.5 |
Type of hedging relationship | Description | Three months ended March 31, | |||||||||
2016 | 2015 | ||||||||||
€873.8 of net investment in foreign operations | Net investment | Hedged item | $ | 45.8 | $ | 2.7 | |||||
€370.0 of term B loan | Net investment | Hedging instrument | (19.4 | ) | — | ||||||
€503.8 of 4.625% senior notes | Net investment | Hedging instrument | (26.4 | ) | (2.7 | ) |
(7) | Commitments and Contingencies |
(8) | Share-Based Compensation |
Three months ended March 31, | |||||||||
Award type | 2016 | 2015 | |||||||
2014 Plan | Stock options | $ | 1.3 | $ | 1.1 | ||||
VWR ESPP | Discounted shares of common stock | 0.1 | — | ||||||
Total | $ | 1.4 | $ | 1.1 |
Three months ended March 31, 2016 | ||||||||||||
Number of stock options | Weighted average exercise price per share | Aggregate intrinsic value | Weighted average remaining term in years | |||||||||
Outstanding at beginning of period | 3.2 | $ | 21.03 | |||||||||
Granted | 2.8 | 24.63 | ||||||||||
Forfeited | (0.1 | ) | 21.00 | |||||||||
Outstanding at end of period | 5.9 | 22.73 | $ | 25.6 | 6.2 | |||||||
Expected to vest at end of period | 5.5 | $ | 22.71 | $ | 24.1 | 6.2 | ||||||
Exercisable at end of period | 0.1 | 21.00 | 0.5 | 5.5 |
Weighted average grant date fair value | $ | 6.69 | |
Expected stock price volatility | 30 | % | |
Risk free interest rate | 1.16 | % | |
Expected dividend rate | 0.0 | % | |
Expected life of options in years | 4.6 |
U.S. Retirement Plan | German, French and UK Plans | ||||||||||||||
Three months ended March 31, | Three months ended March 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Service cost | $ | 0.2 | $ | 0.2 | $ | 0.4 | $ | 0.4 | |||||||
Interest cost | 1.7 | 1.9 | 1.2 | 1.3 | |||||||||||
Expected return on plan assets | (3.3 | ) | (3.6 | ) | (1.2 | ) | (1.2 | ) | |||||||
Recognized net actuarial loss | — | — | 0.8 | 0.9 | |||||||||||
Net periodic pension (income) cost | $ | (1.4 | ) | $ | (1.5 | ) | $ | 1.2 | $ | 1.4 |
(10) | Comprehensive Income or Loss |
Foreign currency translation | Derivative instruments | Defined benefit plans | Total | ||||||||||||
Balance at December 31, 2015 | $ | (365.3 | ) | $ | 2.0 | $ | (43.0 | ) | $ | (406.3 | ) | ||||
Net unrealized gain (loss) arising during the period | 44.2 | (0.8 | ) | — | 43.4 | ||||||||||
Reclassification of net (gain) loss into earnings | — | (0.9 | ) | 0.6 | (0.3 | ) | |||||||||
Balance at March 31, 2016 | $ | (321.1 | ) | $ | 0.3 | $ | (42.4 | ) | $ | (363.2 | ) |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Derivative instruments: | |||||||
Cost of goods sold | $ | (1.1 | ) | $ | (0.4 | ) | |
Interest expense | — | 0.1 | |||||
Loss on extinguishment of debt | — | 0.2 | |||||
Income tax provision | 0.2 | 0.1 | |||||
Net income | $ | (0.9 | ) | $ | — | ||
Defined benefit plans: | |||||||
Selling, general and administrative expenses | $ | 0.8 | $ | 1.0 | |||
Income tax provision | (0.2 | ) | (0.3 | ) | |||
Net income | $ | 0.6 | $ | 0.7 |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Foreign currency translation: | |||||||
Net unrealized income tax benefit arising during the period | $ | 17.8 | $ | — | |||
Derivative instruments: | |||||||
Net unrealized income tax benefit (provision) arising during the period | 0.4 | (0.1 | ) | ||||
Reclassification of net income tax provision into earnings | 0.2 | 0.1 | |||||
Defined benefit plans: | |||||||
Reclassification of net income tax benefit into earnings | (0.2 | ) | (0.3 | ) |
(11) | Related Party Transactions |
(12) | Segment Financial Information |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Net sales: | |||||||
Americas | $ | 666.7 | $ | 605.3 | |||
EMEA-APAC | 431.6 | 424.3 | |||||
Total | $ | 1,098.3 | $ | 1,029.6 | |||
Operating income: | |||||||
Americas | $ | 43.4 | $ | 35.7 | |||
EMEA-APAC | 36.3 | 38.1 | |||||
Total | $ | 79.7 | $ | 73.8 |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | Net sales, organic net sales growth, operating income and operating income margin, which we discuss on both a consolidated and reportable segment basis in the section entitled “Results of Operations.” Organic net sales growth is a non-GAAP financial measurement and a key performance indicator used by our investors and management to measure and evaluate our underlying commercial operating performance. |
• | Gross margin, net income and Adjusted EPS, which we discuss on a consolidated basis in the section entitled “Results of Operations.” Adjusted EPS is a non-GAAP financial measurement and a key performance indicator used by our investors and management to measure and evaluate our operating performance; and |
• | Cash flows, particularly cash flows from operating activities, which we discuss in the section entitled “Liquidity and Capital Resources — Historical Cash Flows.” |
Three months ended March 31, | Reported change | |||||||||||||
2016 | 2015 | Amount | % | |||||||||||
Net sales | $ | 1,098.3 | $ | 1,029.6 | $ | 68.7 | 6.7 | % | ||||||
Organic net sales growth | 6.0 | % | 3.6 | % | ||||||||||
Gross margin | 28.3 | % | 28.3 | % | — | |||||||||
Operating income | $ | 79.7 | $ | 73.8 | $ | 5.9 | 8.0 | % | ||||||
Operating income margin | 7.3 | % | 7.2 | % | 10 | basis points | ||||||||
Net income | $ | 38.8 | $ | 71.5 | $ | (32.7 | ) | (45.7 | )% | |||||
Adjusted EPS | $ | 0.40 | $ | 0.33 | $ | 0.07 | 21.2 | % |
• | Organic net sales growth of 6.0%. The Americas reported organic net sales growth of 7.6%, and EMEA-APAC reported organic net sales growth of 3.6%; |
• | Gross margin was flat, as pricing benefits were offset by growth in services and product mix; |
• | Operating income margin increased 10 basis points, with Americas operating income margin expanding 60 basis points and EMEA-APAC operating income margin declining 60 basis points; |
• | Net income declined due to the absence of a significant non-cash net foreign currency remeasurement gain from our debt in the first quarter of 2015; and |
• | Strong net sales growth and an $8.0 million decline in interest expense resulted in first quarter Adjusted EPS of $0.40, up 21.2%. |
Three months ended March 31, | Reported change | Components of reported change | |||||||||||||||||||||||||||
Currency translation | Acquisitions | Organic net sales growth | |||||||||||||||||||||||||||
2016 | 2015 | Amount | % | Amount | % | ||||||||||||||||||||||||
Americas | $ | 666.7 | $ | 605.3 | $ | 61.4 | 10.1 | % | $ | (6.5 | ) | $ | 21.8 | $ | 46.1 | 7.6 | % | ||||||||||||
EMEA-APAC | 431.6 | 424.3 | 7.3 | 1.7 | % | (12.8 | ) | 4.9 | 15.2 | 3.6 | % | ||||||||||||||||||
Total | $ | 1,098.3 | $ | 1,029.6 | $ | 68.7 | 6.7 | % | $ | (19.3 | ) | $ | 26.7 | $ | 61.3 | 6.0 | % |
Three months ended March 31, | Reported change | Components of reported change | |||||||||||||||||||||||
Currency translation | Operations | ||||||||||||||||||||||||
2016 | 2015 | Amount | % | Amount | % | ||||||||||||||||||||
Gross profit | $ | 310.6 | $ | 291.2 | $ | 19.4 | 6.7 | % | $ | (5.6 | ) | $ | 25.0 | 8.6 | % | ||||||||||
Gross margin | 28.3 | % | 28.3 | % | — |
Three months ended March 31, | Reported change | Components of reported change | |||||||||||||||||||||||
Currency translation | Operations | ||||||||||||||||||||||||
2016 | 2015 | Amount | % | Amount | % | ||||||||||||||||||||
SG&A expenses | $ | 230.9 | $ | 217.4 | $ | 13.5 | 6.2 | % | $ | (4.8 | ) | $ | 18.3 | 8.4 | % | ||||||||||
SG&A expenses as a percentage of net sales | 21.0 | % | 21.1 | % | (10 | ) | basis points |
Three months ended March 31, | Reported change | Components of reported change | |||||||||||||||||||||||
Currency translation | Operations | ||||||||||||||||||||||||
2016 | 2015 | Amount | % | Amount | % | ||||||||||||||||||||
Operating income: | |||||||||||||||||||||||||
Americas | $ | 43.4 | $ | 35.7 | $ | 7.7 | 21.6 | % | $ | — | $ | 7.7 | 21.6 | % | |||||||||||
EMEA-APAC | 36.3 | 38.1 | (1.8 | ) | (4.7 | )% | (0.8 | ) | (1.0 | ) | (2.6 | )% | |||||||||||||
Total | $ | 79.7 | $ | 73.8 | $ | 5.9 | 8.0 | % | $ | (0.8 | ) | $ | 6.7 | 9.1 | % | ||||||||||
Operating income margin: | |||||||||||||||||||||||||
Americas | 6.5 | % | 5.9 | % | 60 | basis points | |||||||||||||||||||
EMEA-APAC | 8.4 | % | 9.0 | % | (60 | ) | basis points | ||||||||||||||||||
Total | 7.3 | % | 7.2 | % | 10 | basis points |
Three months ended March 31, | Reported change | |||||||||||||
2016 | 2015 | Amount | % | |||||||||||
Operating income | $ | 79.7 | $ | 73.8 | $ | 5.9 | 8.0 | % | ||||||
Interest expense | (19.2 | ) | (27.2 | ) | 8.0 | 29.4 | % | |||||||
Other income (expense), net | (0.6 | ) | 70.3 | (70.9 | ) | n/m | ||||||||
Loss on extinguishment of debt | — | (1.8 | ) | 1.8 | n/m | |||||||||
Income tax provision | (21.1 | ) | (43.6 | ) | 22.5 | 51.6 | % | |||||||
Net income | $ | 38.8 | $ | 71.5 | $ | (32.7 | ) | (45.7 | )% |
• | Higher operating income, up $5.9 million compared to prior year; |
• | Interest expense, which decreased $8.0 million due to debt refinancing activity in 2015; |
• | The 2015 loss on extinguishment of debt of $1.8 million, which was caused by the write-off of unamortized deferred financing costs following the repayment of term loans in 2015; and |
• | Lower income tax provision, primarily due to the absence of the non-cash remeasurement gain described above. The effective tax rate was similar to the rate for the year ended December 31, 2015 as described in Note 18 to the consolidated financial statements in our Annual Report. |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Net income | $ | 38.8 | $ | 71.5 | |||
Amortization of acquired intangible assets | 21.0 | 20.8 | |||||
Net foreign currency remeasurement loss (gain) from financing activities | 0.6 | (70.3 | ) | ||||
Loss on extinguishment of debt | — | 1.8 | |||||
Secondary equity offering costs | 0.4 | — | |||||
Loss from changes to estimated fair value of contingent consideration | 0.2 | — | |||||
Legacy facility exit charges | — | 1.4 | |||||
Income tax (benefit) provision applicable to adjustments, net | (7.8 | ) | 18.6 | ||||
Net income, as adjusted | $ | 53.2 | $ | 43.8 | |||
Adjusted EPS | $ | 0.40 | $ | 0.33 | |||
Weighted average shares outstanding, diluted | 131.6 | 131.9 |
A/R Facility | Multi-currency revolving loan facility | Total | |||||||||
Maximum availability | $ | 175.0 | $ | 250.0 | $ | 425.0 | |||||
Current availability | $ | 167.6 | $ | 250.0 | $ | 417.6 | |||||
Undrawn letters of credit outstanding | (11.4 | ) | (12.1 | ) | (23.5 | ) | |||||
Outstanding borrowings | (118.2 | ) | — | (118.2 | ) | ||||||
Unused availability | $ | 38.0 | $ | 237.9 | $ | 275.9 |
Three months ended March 31, | |||||||
2016 | 2015 | ||||||
Net cash provided by (used in): | |||||||
Operating activities | $ | 42.0 | $ | (9.9 | ) | ||
Investing activities | (43.2 | ) | (24.9 | ) | |||
Financing activities | (10.3 | ) | 23.8 |
Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
Item 4. | Controls and Procedures |
Item 1. | Legal Proceedings |
Item 1A. | Risk Factors |
• | the election of the Board and the appointment and removal of our officers; |
• | mergers and other business combination transactions, including proposed transactions that would result in our stockholders receiving a premium price for their shares; |
• | other acquisitions or dispositions of businesses or assets; |
• | incurrence of indebtedness and the issuance of equity securities; |
• | repurchase of stock and payment of dividends; and |
• | the issuance of shares to management under our equity incentive plans. |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
Item 3. | Defaults Upon Senior Securities |
Item 4. | Mine Safety Disclosures |
Item 5. | Other Information |
Item 6. | Exhibits |
VWR Corporation | |||
Date: May 5, 2016 | By: | /s/ Douglas J. Pitts | |
Name: | Douglas J. Pitts | ||
Title: | Vice President and Corporate Controller (Chief Accounting Officer and Duly Authorized Officer) |
Exhibit No. | Exhibit Description | Method of Filing | |||
31.1 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith | |||
31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith | |||
32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) | Furnished herewith | |||
32.2 | Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) | Furnished herewith | |||
101.INS | XBRL Instance Document | Filed herewith | |||
101.SCH | XBRL Taxonomy Extension Schema Document | Filed herewith | |||
101.CAL | XBRL Taxonomy Calculation Linkbase Document | Filed herewith | |||
101.LAB | XBRL Taxonomy Label Linkbase Document | Filed herewith | |||
101.PRE | XBRL Taxonomy Presentation Linkbase Document | Filed herewith | |||
101.DEF | XBRL Taxonomy Definition Linkbase Document | Filed herewith |
1. | I have reviewed this Quarterly Report on Form 10-Q of VWR Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Manuel Brocke-Benz | |
Name: Manuel Brocke-Benz | |
Title: President and Chief Executive Officer | |
Date: May 5, 2016 |
1. | I have reviewed this Quarterly Report on Form 10-Q of VWR Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Gregory L. Cowan | |
Name: Gregory L. Cowan | |
Title: Senior Vice President and Chief Financial Officer | |
Date: May 5, 2016 |
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Manuel Brocke-Benz | |
Name: Manuel Brocke-Benz | |
Title: President and Chief Executive Officer | |
Date: May 5, 2016 |
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Gregory L. Cowan | |
Name: Gregory L. Cowan | |
Title: Senior Vice President and Chief Financial Officer | |
Date: May 5, 2016 |
'M[>WQ\?']_?X>' MAXR,C(^/CY24E)>7EYF9F9J:FI^?GZ>GIZBHJ*^OK[*RLK>WM[R\O+V]O;^_ MO\?'Q\_/S]#0T-?7U]G9V=_?W^'AX>?GY^GIZ>_O[_#P\/?W]____P M M M M M M M M M M M /_[\*"@I(" @/\ #_ M /__ __\ _P#______R'Y! $ %, + !&!J,!AP ( " (" M @( @ " @,# P,#
'M[>WQ\?']_?X>'AXR,C(^/CY24E)>7EYF9F9J:FI^?GZ>G
MIZBHJ*^OK[*RLK>WM[R\O+V]O;^_O\?'Q\_/S]#0T-?7U]G9V=_?W^'AX>?G
MY^GIZ>_O[_#P\/?W]____P
M
M
M
M
M
M
M
M
M
M
M /_[\*"@I(" @/\ #_ /__ __\ _P#______PC^ *<('$BP
MH,"!,J7,BPH<.'$"-*G$BQHL6+-JW,BQH\>/($.*'$FRI,F3*%.J7,FR
MI )=?;#P[!(WWHBX_
M.TBVR#F,I!!);$A*U, ARBMI!I(*Z&0$;F5(:'9M)$HXH%-O:/+SQ$?=Y,
M):C0(2Z(8 ^PJD2([PMG29E
M5L)L) X%ERE=/K,MD;$7DE!/F1+$K 5(=WW'1
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MM)<433;?S/_\S0 >T0/T0S\T1$>T1#\S(R.T15]T$LO
M1&\T1W>T1W\T2(?T,LL 1I>T20/Q#Z2R2*\T2[>T2[\T3&=S!5#H2=>T37>P
M%-B 2LK
MI^HN_[)K\ ;G\P;D)<"/_EZ)][S)(/JCA+ ETA9$_
Document and entity information - shares |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Apr. 28, 2016 |
|
Document and Entity Information [Abstract] | ||
Document type | 10-Q | |
Document period end date | Mar. 31, 2016 | |
Amendment flag | false | |
Entity registrant name | VWR Corporation | |
Entity central index key | 0001412232 | |
Current fiscal year end date | --12-31 | |
Entity filer category | Large Accelerated Filer | |
Document fiscal year focus | 2016 | |
Document fiscal period focus | Q1 | |
Entity common stock, shares outstanding | 131,419,375 |
Condensed consolidated balance sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Reserves on trade accounts receivable | $ 10.8 | $ 12.0 |
Preferred stock, par value per share | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 50.0 | 50.0 |
Preferred stock, shares issued | 0.0 | 0.0 |
Preferred stock, shares outstanding | 0.0 | 0.0 |
Common stock, par value per share | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 750.0 | 750.0 |
Common stock, shares issued | 131.4 | 131.4 |
Common stock, shares outstanding | 131.4 | 131.4 |
Condensed consolidated statements of operations - USD ($) shares in Millions, $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Income Statement [Abstract] | ||
Net sales | $ 1,098.3 | $ 1,029.6 |
Cost of goods sold | 787.7 | 738.4 |
Gross profit | 310.6 | 291.2 |
Selling, general and administrative expenses | 230.9 | 217.4 |
Operating income | 79.7 | 73.8 |
Interest expense | (19.2) | (27.2) |
Other income (expense), net | (0.6) | 70.3 |
Loss on extinguishment of debt | 0.0 | (1.8) |
Income before income taxes | 59.9 | 115.1 |
Income tax provision | (21.1) | (43.6) |
Net income | $ 38.8 | $ 71.5 |
Earnings per share: | ||
Basic | $ 0.30 | $ 0.54 |
Diluted | $ 0.29 | $ 0.54 |
Weighted average shares outstanding: | ||
Basic | 131.4 | 131.4 |
Diluted | 131.6 | 131.9 |
Condensed consolidated statements of comprehensive income or loss - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 38.8 | $ 71.5 |
Foreign currency translation: | ||
Net unrealized gain (loss) arising during the period | 44.2 | (166.0) |
Derivative instruments: | ||
Net unrealized (loss) gain arising during the period | (0.8) | 0.1 |
Reclassification of net gain into earnings | (0.9) | 0.0 |
Defined benefit plans: | ||
Reclassification of net loss into earnings | 0.6 | 0.7 |
Other comprehensive income (loss) | 43.1 | (165.2) |
Comprehensive income (loss) | $ 81.9 | $ (93.7) |
Nature of operations and basis of presentation (Notes) |
3 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||
Nature of operations and basis of presentation |
VWR Corporation, together with its consolidated subsidiaries (the “Company,” “we,” “us,” and “our”), is a leading, independent provider of laboratory products, services and solutions to the global life science, general research and applied markets. We have significant market positions in Europe and North America. We also have operations in Asia-Pacific and other key emerging markets to support our multinational customers across the globe. We serve a critical role in connecting customer sites with laboratory product suppliers across multiple industries and geographies. We offer a broad portfolio of branded and private label laboratory products. We also offer a full range of value-added services, including custom manufacturing, to meet our customers’ needs. These services represent a growing but currently small portion of our overall net sales. We offer a wide selection of unique products and have developed an extensive global infrastructure including thousands of sales and service-focused professionals. We deliver value to our customers by improving the costs, efficiency and effectiveness of their research laboratories and production operations. We deliver value to our suppliers by providing them with cost-effective channel access to a global and diverse customer base. Basis of Presentation We report financial results on the basis of two reportable segments organized by geographic region: (i) North, Central and South America (collectively, the “Americas”); and (ii) Europe, Middle East, Africa and Asia Pacific (collectively, “EMEA-APAC”). We have prepared these condensed consolidated financial statements without audit pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles has been condensed or omitted pursuant to such rules and regulations. The financial information presented herein reflects all adjustments (consisting only of normal, recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The results for interim periods are not necessarily indicative of the results to be expected for the full year. We believe that the disclosures included herein are adequate to make the information presented not misleading in any material respect when read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2015 included in our most recent Annual Report on Form 10-K. Those audited consolidated financial statements include a summary of our significant accounting policies, to which there have been no material changes. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of VWR Corporation and its subsidiaries, as well as redeemable equity and share-based compensation expense related to Varietal Distribution Holdings, LLC, each after the elimination of intercompany balances and transactions. The following describes our corporate organization at March 31, 2016 and the principles followed in consolidating our financial statements: ![]()
In April 2016, Varietal completed a sale of our common stock that caused it to no longer hold a majority ownership interest in us. As a result, we experienced a change in control under U.S. federal tax regulations which may impact (i) the amount and timing of the utilization of our net operating loss carryforwards; (ii) the timing of payments under an income tax receivable agreement with Varietal (“ITRA,” see Note 11); and (iii) the amount of cash taxes we expect to pay in future periods. Additionally, Varietal can no longer compel us to fund future redemptions of equity units through control of our board of directors.
Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue, expenses, income and loss during the reporting period. Actual results could differ significantly from those estimates. |
New accounting standards (Notes) |
3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2016 | |||||
Accounting Changes and Error Corrections [Abstract] | |||||
New accounting standards |
In March 2016, the Financial Accounting Standards Board (“FASB”) issued new guidance that simplifies several aspects of accounting for share-based compensation as well as classification in the statement of cash flows. The new guidance is effective for us beginning in the first quarter of 2017, with early adoption permitted. We expect to adopt the guidance prospectively and do not expect that the standard will result in a material change to our financial statements. In February 2016, the FASB issued comprehensive new guidance about leases. Under the new guidance, most leases will be recognized on our consolidated balance sheet as liabilities with corresponding right-of-use assets. The new guidance is effective for us beginning in the first quarter of 2019, with early adoption permitted. The standard must be adopted using a modified retrospective approach. We have not yet evaluated the impact of this new pronouncement. In May 2014, the FASB issued comprehensive revenue recognition guidance. The new guidance provides a single model for entities to use in accounting for revenue arising from contracts with customers and will supersede most current revenue recognition guidance. The new standard also requires expanded disclosures regarding the qualitative and quantitative information about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new guidance is effective for us beginning in the first quarter of 2018. The standard may be adopted using either a full retrospective or a modified retrospective approach. We are continuing to evaluate the impact of this pronouncement and the method by which we will adopt it. |
Earnings per share (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||
Earnings per share |
The following table presents the reconciliation of weighted average shares outstanding used to calculate basic and diluted earnings per share (in millions):
For the three months ended March 31, 2016, 2.9 million anti-dilutive share-based instruments were excluded from the calculation of diluted earnings per share. |
Goodwill and other intangible assets, net (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and other intangible assets, net |
The following table presents changes in goodwill by segment (in millions):
The following table presents the gross amount of goodwill and accumulated impairment losses by segment (in millions):
The following table presents the components of other intangible assets (in millions):
|
Debt (Notes) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt |
The following table presents information about debt (dollars in millions):
In the table above, discounts include unamortized original issue discounts and debt issuance costs, EURIBOR is subject to a floor of 0.75% and other debt includes capital lease obligations and subsidiary loans from local banks. Borrowings under the accounts receivable securitization facility and the multi-currency revolving credit facility, if any, are included in the current portion of debt because we frequently borrow from and repay them to satisfy short term cash requirements. In April 2016, we entered into two interest rate swaps that exchange the variable LIBOR rate on portions of our term A loan for fixed rates. See Note 6. The following table presents availability under credit facilities at March 31, 2016 (in millions):
|
Financial instruments and fair value measurements (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial instruments and fair value measurements |
Our financial instruments include cash and cash equivalents, trade accounts receivable, accounts payable, debt and an amount due to Varietal under the ITRA. Except for the amount due to Varietal, these financial instruments are held or issued by a number of institutions, which reduces the risk of material non-performance. Assets and Liabilities for which Fair Value is Only Disclosed The carrying amount of cash and cash equivalents is the same as its fair value and is a Level 1 measurement. The carrying amounts for trade accounts receivable and accounts payable approximate fair value due to their short-term nature and are Level 2 measurements. The following table presents the carrying amounts and fair values of debt instruments (in millions):
The fair values of debt instruments are based on quoted market prices and standard pricing models that take into account the present value of future cash flows, which are Level 2 measurements. At March 31, 2016 and December 31, 2015, the amount due to Varietal under the ITRA (see Note 11) had carrying amounts of $85.0 million and $163.1 million, respectively, and fair values of $70.5 million and $147.6 million, respectively. The fair values were estimated using a combination of observable and unobservable inputs using an income-based approach, a Level 3 measurement. Recurring Fair Value Measurements with Significant Unobservable Inputs The following table presents changes in contingent consideration liabilities, which are measured at fair value on a recurring basis using Level 3 measurements (in millions):
Certain of the business acquisitions we completed entitle the sellers to contingent consideration if earnings targets are met during a period of time following the acquisition. We estimate their fair value using the average of probability-weighted potential earn-out payments specified in the purchase agreements, ranging in the aggregate from approximately $1 million to $34 million for all open earn-outs at March 31, 2016. The significant assumptions used in these calculations include forecasted results and the estimated likelihood for each performance scenario. Derivative Instruments and Hedging Activities We engage in hedging activities to reduce our exposure to changes in variable interest rates and foreign currency exchange rates. Our hedging activities are designed to manage specific risks according to our strategies, as summarized below, which may change from time to time. Our hedging activities consist of the following:
Variable Interest Rate Hedging In April 2016, we entered into two interest rate swaps that we designated as cash flow hedges of the variable LIBOR rate on our term A loan. Beginning April 2016, we swapped LIBOR for a 1.00% fixed rate on $375.0 million of our term A loan. Beginning September 2016, we will swap LIBOR for a 1.05% fixed rate on an additional $125.0 million of our term A loan. Both interest rate swaps mature on September 28, 2020. We expect that these hedges will be highly effective, therefore changes to the fair value of the interest rate swaps, which otherwise would be recognized in earnings, will be deferred as accumulated other comprehensive income or loss. Net Investment Hedging We have designated €370.0 million of our term B loan and all €503.8 million of our 4.625% senior notes as hedges to protect a portion of our net investment in euro-denominated foreign operations from the impact of changes in the euro to U.S. dollar exchange rate. As a result of the hedge designations, the net foreign currency remeasurement gain or loss on the hedging instruments, which otherwise would be recognized in earnings, is deferred as accumulated other comprehensive income or loss. That deferred net gain or loss equally offsets the net unrealized gain or loss that is recognized in other comprehensive income or loss from the translation of the hedged portion of our net investment in euro-denominated foreign operations. The hedge has no other impact to our financial position, financial performance or cash flows. Tabular Disclosures The following table presents the balance sheet classification and fair value of liability instruments in hedging relationships, all of which are Level 2 measurements (in millions):
The following table presents information about the net unrealized gain (loss) recognized in other comprehensive income or loss resulting from liability instruments in hedging relationships and hedged items (in millions):
We determined that all of our hedges were fully effective for the three months ended March 31, 2016 and 2015. No amounts were recognized in or reclassified to earnings as a result of net investment hedging. |
Commitments and contingencies (Notes) |
3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2016 | |||||
Commitments and Contingencies Disclosure [Abstract] | |||||
Commitments and contingencies |
Our business involves risk of product liability, patent infringement and other claims in the ordinary course of business arising from the products that we source from various manufacturers or produce ourselves, as well as from the services we provide. Our exposure to such claims may increase as we seek to increase the geographic scope of our sourcing activities and sales of private label products and to the extent that we expand our manufacturing operations or service offerings. We maintain insurance policies, including product liability insurance, and in many cases the manufacturers of the products we distribute have indemnified us against such claims. We cannot assure you that our insurance coverage or indemnification agreements with manufacturers will be available in all pending or any future cases brought against us. Furthermore, our ability to recover under any insurance or indemnification arrangements is subject to the financial viability of our insurers, our manufacturers and our manufacturers’ insurers, as well as legal enforcement under the local laws governing the arrangements. In particular, as we seek to expand our sourcing from manufacturers in the Asia-Pacific region and other developing locations, we expect that we will increase our exposure to potential defaults under the related indemnification arrangements. Insurance coverage in general or coverage for certain types of liabilities, such as product liability or patent infringement in these developing markets may not be readily available for purchase or cost-effective for us to purchase. Furthermore, insurance for liability relating to asbestos, lead and silica exposure is not available, and we do not maintain insurance for product recalls. Accordingly, we could be subject to uninsured and unindemnified future liabilities, and an unfavorable result in a case for which adequate insurance or indemnification is not available could result in a material adverse effect on our business, financial condition and results of operations. We are also involved in various disputes, litigation and regulatory matters incidental to our business, including employment matters, commercial disputes, government contract compliance matters, disputes regarding environmental clean-up costs, and other matters arising out of the normal conduct of our business. We intend to vigorously defend ourselves in such matters. From time to time, we are named as a defendant in cases as a result of our distribution of laboratory supplies, including litigation resulting from the alleged prior distribution of products containing asbestos by certain of our predecessors or acquired companies. While the impact of these disputes or litigation has historically been immaterial, and we believe the range of reasonably possible loss from current matters continues to be immaterial, there can be no assurance that the impact of the pending and any future claims will not be material to our business, financial condition or results of operations in the future. Employment Agreements The employment agreements with our executive officers include provisions for the payment of severance and continuing health benefits following termination without cause or resignation for good reason, as those terms are defined in the employment agreements. The aggregate of potential payments for all executive offers under these provisions was $10.3 million at March 31, 2016. Registration Rights Agreement We are party to a registration rights agreement with Varietal that could require us to pay securities registration costs in future periods. Under the registration rights agreement, Varietal is entitled to request that we register (i) any shares of our common stock that it held at October 7, 2014 and (ii) any shares held by Madison Dearborn Partners. Should we register such common stock, we would be required to pay costs related to the registration as well as Varietal’s expenses in connection with its exercise of these rights. During the three months ended March 31, 2016, we incurred expenses of $0.4 million pursuant to the registration rights agreement. See Note 11. |
Share-based compensation (Notes) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation |
The following table presents the components of share-based compensation expense, a component of selling, general and administrative expenses (in millions):
At March 31, 2016, remaining share-based compensation expense of $31.8 million related to unvested awards will be recognized over a weighted average period of 3.7 years. VWR Corporation 2014 Equity Incentive Plan The VWR Corporation 2014 Equity Incentive Plan (the “2014 Plan”) authorized up to 11.5 million shares of common stock to be issued in the form of stock options, stock appreciation rights, restricted stock or other stock-based awards. At March 31, 2016, 5.6 million shares were available for future issuance. No award shall be granted pursuant to the 2014 Plan on or after September 9, 2024. Stock Options The following table presents information about stock options under the 2014 Plan (in millions, except per share amounts and years):
On March 2, 2016, we granted stock options to management under the 2014 Plan. The stock options vest 25% on the first anniversary of the date of grant and 6.25% quarterly thereafter through the fourth anniversary of the date of grant and have a seven-year term. The following table presents information about the fair value of stock options granted in 2016:
|
Benefit plans (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Benefit plans | (9) Benefit Plans The following table presents the components of net periodic pension income or cost (in millions):
During the three months ended March 31, 2016, we made no contributions to the U.S. Retirement Plan and $0.1 million of aggregate contributions to the German, French and UK Plans. For the remainder of 2016, we expect to make no contributions to the U.S. Retirement Plan and aggregate contributions of $5.7 million to the German, French and UK Plans. |
Comprehensive income or loss (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comprehensive income or loss |
The following table presents changes in the components of accumulated other comprehensive income (loss), net of tax (in millions):
The following table presents information about the reclassification of net (gain) loss from accumulated other comprehensive income or loss into earnings (in millions):
The following table presents the income tax effects of the components of comprehensive income or loss (in millions):
|
Related party transactions (Notes) |
3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2016 | |||||
Related Party Transactions [Abstract] | |||||
Related party transactions |
Due to Varietal — ITRA We are party to an ITRA with Varietal. The ITRA provides for the payment of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax realized as a result of utilizing net operating losses that were generated in periods prior to the IPO. As noted previously, Madison Dearborn Partners own a controlling interest in Varietal. The timing of payments under the ITRA corresponds to the year subsequent to the year in which the net operating loss carryforwards are claimed on our tax return. We made a payment under the ITRA of $78.1 million during the three months ended March 31, 2016. At March 31, 2016, the amount due to Varietal under the ITRA was $85.0 million, $33.2 million of which is classified as current and represents our estimate of the payment that will become due in March 2017. Registration Rights Agreement In April 2016, Varietal completed a registered sale of 9.2 million shares of our common stock. We received no proceeds from this sale and issued no additional shares of our common stock. Pursuant to our registration rights agreement with Varietal (see Note 7), we incurred expenses of $0.4 million related to the registered sale during the three months ended March 31, 2016. |
Segment financial information (Notes) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment financial information |
The following table presents segment financial information (in millions):
Inter-segment activity has been eliminated; therefore, net sales for each reportable segment are all from external customers. We determined that disclosing net sales for each group of similar customers, products and services would be impracticable. |
Nature of operations and basis of presentation (Policies) |
3 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||
Basis of presentation | Basis of Presentation We report financial results on the basis of two reportable segments organized by geographic region: (i) North, Central and South America (collectively, the “Americas”); and (ii) Europe, Middle East, Africa and Asia Pacific (collectively, “EMEA-APAC”). We have prepared these condensed consolidated financial statements without audit pursuant to the rules and regulations of the United States Securities and Exchange Commission. Certain information normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles has been condensed or omitted pursuant to such rules and regulations. The financial information presented herein reflects all adjustments (consisting only of normal, recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. The results for interim periods are not necessarily indicative of the results to be expected for the full year. We believe that the disclosures included herein are adequate to make the information presented not misleading in any material respect when read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2015 included in our most recent Annual Report on Form 10-K. Those audited consolidated financial statements include a summary of our significant accounting policies, to which there have been no material changes. |
||||||||
Principles of consolidation | Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of VWR Corporation and its subsidiaries, as well as redeemable equity and share-based compensation expense related to Varietal Distribution Holdings, LLC, each after the elimination of intercompany balances and transactions. The following describes our corporate organization at March 31, 2016 and the principles followed in consolidating our financial statements: ![]()
In April 2016, Varietal completed a sale of our common stock that caused it to no longer hold a majority ownership interest in us. As a result, we experienced a change in control under U.S. federal tax regulations which may impact (i) the amount and timing of the utilization of our net operating loss carryforwards; (ii) the timing of payments under an income tax receivable agreement with Varietal (“ITRA,” see Note 11); and (iii) the amount of cash taxes we expect to pay in future periods. Additionally, Varietal can no longer compel us to fund future redemptions of equity units through control of our board of directors.
|
||||||||
Use of estimates | Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue, expenses, income and loss during the reporting period. Actual results could differ significantly from those estimates. |
Earnings per share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||
Schedule of earnings per share | The following table presents the reconciliation of weighted average shares outstanding used to calculate basic and diluted earnings per share (in millions):
|
Goodwill and other intangible assets, net (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of goodwill | The following table presents changes in goodwill by segment (in millions):
The following table presents the gross amount of goodwill and accumulated impairment losses by segment (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of other intangible assets, amortizable | The following table presents the components of other intangible assets (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of other intangible assets, indefinite-lived | The following table presents the components of other intangible assets (in millions):
|
Debt (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about debt | The following table presents information about debt (dollars in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of availability under credit facilities | The following table presents availability under credit facilities at March 31, 2016 (in millions):
|
Financial instruments and fair value measurements (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of carrying amounts and fair values of debt instruments | The following table presents the carrying amounts and fair values of debt instruments (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in recurring fair value measurements | The following table presents changes in contingent consideration liabilities, which are measured at fair value on a recurring basis using Level 3 measurements (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of net investment hedging | The following table presents the balance sheet classification and fair value of liability instruments in hedging relationships, all of which are Level 2 measurements (in millions):
The following table presents information about the net unrealized gain (loss) recognized in other comprehensive income or loss resulting from liability instruments in hedging relationships and hedged items (in millions):
|
Share-based compensation (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of share-based compensation expense | The following table presents the components of share-based compensation expense, a component of selling, general and administrative expenses (in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about stock options | The following table presents information about stock options under the 2014 Plan (in millions, except per share amounts and years):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about the fair value of stock options granted | The following table presents information about the fair value of stock options granted in 2016:
|
Benefit plans (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Retirement Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of net periodic pension income or cost | The following table presents the components of net periodic pension income or cost (in millions):
|
Comprehensive income or loss (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in components of accumulated other comprehensive income or loss | The following table presents changes in the components of accumulated other comprehensive income (loss), net of tax (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of reclassifications of net gain or loss from accumulated other comprehensive income or loss into earnings | The following table presents information about the reclassification of net (gain) loss from accumulated other comprehensive income or loss into earnings (in millions):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of income tax effects of the components of comprehensive income or loss | The following table presents the income tax effects of the components of comprehensive income or loss (in millions):
|
Segment financial information (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of segment financial information | The following table presents segment financial information (in millions):
|
Nature of operations and basis of presentation (Details) - Segment |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Apr. 04, 2016 |
|
Nature of operations and basis of presentation | ||
Number of reportable segments | 2 | |
Ownership percentage, Varietal | 54.00% | |
Ownership percentage, public investors | 46.00% | |
Subsequent event | ||
Nature of operations and basis of presentation | ||
Ownership percentage, Varietal | 47.00% | |
Ownership percentage, public investors | 53.00% |
Earnings per share (Details) - shares shares in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Earnings Per Share [Abstract] | ||
Weighted average shares outstanding, basic | 131.4 | 131.4 |
Dilutive effect of share-based instruments | 0.2 | 0.5 |
Weighted average shares outstanding, diluted | 131.6 | 131.9 |
Anti-dilutive instruments excluded from calculation | 2.9 |
Goodwill and other intangible assets, net - Changes in goodwill (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Changes in goodwill | |
Beginning balance | $ 1,791.4 |
Acquisitions | 16.8 |
Currency translation | 38.3 |
Ending balance | 1,846.5 |
Americas | |
Changes in goodwill | |
Beginning balance | 1,046.3 |
Acquisitions | 16.7 |
Currency translation | 5.3 |
Ending balance | 1,068.3 |
EMEA-APAC | |
Changes in goodwill | |
Beginning balance | 745.1 |
Acquisitions | 0.1 |
Currency translation | 33.0 |
Ending balance | $ 778.2 |
Goodwill and other intangible assets, net - Gross amounts of goodwill (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Goodwill | ||
Gross carrying amount | $ 2,053.1 | $ 1,998.0 |
Accumulated impairment losses | 206.6 | 206.6 |
Net carrying amount | 1,846.5 | 1,791.4 |
Americas | ||
Goodwill | ||
Gross carrying amount | 1,274.9 | 1,252.9 |
Accumulated impairment losses | 206.6 | 206.6 |
Net carrying amount | 1,068.3 | 1,046.3 |
EMEA-APAC | ||
Goodwill | ||
Gross carrying amount | 778.2 | 745.1 |
Accumulated impairment losses | 0.0 | 0.0 |
Net carrying amount | $ 778.2 | $ 745.1 |
Goodwill and other intangible assets, net - Amortizable intangible assets (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Amortizable intangible assets | ||
Gross carrying amount | $ 1,473.9 | $ 1,432.5 |
Accumulated amortization | 629.6 | 596.6 |
Net carrying amount | 844.3 | 835.9 |
Customer relationships | ||
Amortizable intangible assets | ||
Gross carrying amount | 1,439.3 | 1,402.2 |
Accumulated amortization | 611.8 | 581.4 |
Net carrying amount | 827.5 | 820.8 |
Other | ||
Amortizable intangible assets | ||
Gross carrying amount | 34.6 | 30.3 |
Accumulated amortization | 17.8 | 15.2 |
Net carrying amount | $ 16.8 | $ 15.1 |
Goodwill and other intangible assets, net - Other intangible assets (Details) - USD ($) $ in Millions |
Mar. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Gross carrying amount | ||
Amortizable intangible assets | $ 1,473.9 | $ 1,432.5 |
Indefinite-lived intangible assets | 633.0 | 619.7 |
Other intangible assets | 2,106.9 | 2,052.2 |
Net carrying amount | ||
Amortizable intangible assets | 844.3 | 835.9 |
Indefinite-lived intangible assets | 633.0 | 619.7 |
Other intangible assets | $ 1,477.3 | $ 1,455.6 |
Debt - Availability under credit facilities (Details) $ in Millions |
Mar. 31, 2016
USD ($)
|
---|---|
Information about debt | |
Maximum availability | $ 425.0 |
Current availability | 417.6 |
Undrawn letters of credit outstanding | (23.5) |
Outstanding borrowings | (118.2) |
Unused availability | 275.9 |
Accounts receivable securitization facility | |
Information about debt | |
Maximum availability | 175.0 |
Current availability | 167.6 |
Undrawn letters of credit outstanding | (11.4) |
Outstanding borrowings | (118.2) |
Unused availability | 38.0 |
Senior credit facility | Multi-currency revolving loan facility | |
Information about debt | |
Maximum availability | 250.0 |
Current availability | 250.0 |
Undrawn letters of credit outstanding | (12.1) |
Outstanding borrowings | 0.0 |
Unused availability | $ 237.9 |
Financial instruments and fair value measurements - Recurring fair value measurements with significant unobservable inputs (Details) - Recurring - Level 3 - Contingent consideration $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Changes in fair value measurements: | |
Beginning balance | $ 21.0 |
Acquisitions | 7.5 |
Loss from changes to estimated fair value | 0.2 |
Settlements in cash | (1.8) |
Currency translation | (0.2) |
Ending balance | 26.7 |
Information about contingent consideration: | |
Range of outcomes, low | 1.0 |
Range of outcomes, high | $ 34.0 |
Commitments and contingencies (Details) $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2016
USD ($)
| |
Employment agreements | |
Commitments and contingencies: | |
Loss contingency, range of possible loss, maximum | $ 10.3 |
Registration rights agreement | Varietal | |
Commitments and contingencies: | |
Expenses incurred | $ (0.4) |
Benefit plans (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
U.S. Retirement Plan | ||
Net periodic pension cost (income): | ||
Service cost | $ 0.2 | $ 0.2 |
Interest cost | 1.7 | 1.9 |
Expected return on plan assets | (3.3) | (3.6) |
Recognized net actuarial loss | 0.0 | 0.0 |
Net periodic pension (income) cost | (1.4) | (1.5) |
Contributions paid | 0.0 | |
Expected contributions for remainder of year | 0.0 | |
German, French and UK Plans | ||
Net periodic pension cost (income): | ||
Service cost | 0.4 | 0.4 |
Interest cost | 1.2 | 1.3 |
Expected return on plan assets | (1.2) | (1.2) |
Recognized net actuarial loss | 0.8 | 0.9 |
Net periodic pension (income) cost | 1.2 | $ 1.4 |
Contributions paid | 0.1 | |
Expected contributions for remainder of year | $ 5.7 |
Comprehensive income or loss - Reclassifications (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Component of earnings: | ||
Cost of goods sold | $ (787.7) | $ (738.4) |
Selling, general and administrative expenses | (230.9) | (217.4) |
Interest expense | (19.2) | (27.2) |
Income tax provision | (21.1) | (43.6) |
Net income | 38.8 | 71.5 |
Reclassification of (gain) loss from accumulated other comprehensive income or loss into earnings | Derivative instruments | ||
Component of earnings: | ||
Cost of goods sold | (1.1) | (0.4) |
Interest expense | 0.0 | 0.1 |
Loss on extinguishment of debt | 0.0 | 0.2 |
Income tax provision | 0.2 | 0.1 |
Net income | (0.9) | 0.0 |
Reclassification of (gain) loss from accumulated other comprehensive income or loss into earnings | Defined benefit plans | ||
Component of earnings: | ||
Selling, general and administrative expenses | 0.8 | 1.0 |
Income tax provision | (0.2) | (0.3) |
Net income | $ 0.6 | $ 0.7 |
Comprehensive income or loss - Income tax effects (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Foreign currency translation: | ||
Net unrealized income tax benefit arising during the period | $ 17.8 | $ 0.0 |
Derivative instruments: | ||
Net unrealized income tax benefit (provision) arising during the period | 0.4 | (0.1) |
Reclassification of net income tax provision into earnings | 0.2 | 0.1 |
Defined benefit plans: | ||
Reclassification of net income tax benefit into earnings | $ (0.2) | $ (0.3) |
Related party transactions (Details) - USD ($) shares in Millions, $ in Millions |
1 Months Ended | 3 Months Ended | ||
---|---|---|---|---|
Apr. 30, 2016 |
Mar. 31, 2016 |
Mar. 31, 2015 |
Dec. 31, 2015 |
|
Related party transactions | ||||
Payment to related party | $ 78.1 | $ 9.8 | ||
Due to related party, current | $ 33.2 | $ 78.1 | ||
Varietal | Income tax receivable agreement | ||||
Related party transactions | ||||
Percentage of net operating losses payable | 85.00% | |||
Payment to related party | $ 78.1 | |||
Due to related party | 85.0 | |||
Due to related party, current | 33.2 | |||
Varietal | Registration rights agreement | ||||
Related party transactions | ||||
Expenses incurred | $ (0.4) | |||
Varietal | Registration rights agreement | Subsequent event | ||||
Related party transactions | ||||
Number of shares sold | 9.2 | |||
Proceeds from issuance of shares | $ 0.0 | |||
Shares issued | 0.0 |
Segment financial information (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2016 |
Mar. 31, 2015 |
|
Segment financial information | ||
Net sales | $ 1,098.3 | $ 1,029.6 |
Operating income | 79.7 | 73.8 |
Americas | ||
Segment financial information | ||
Net sales | 666.7 | 605.3 |
Operating income | 43.4 | 35.7 |
EMEA-APAC | ||
Segment financial information | ||
Net sales | 431.6 | 424.3 |
Operating income | $ 36.3 | $ 38.1 |
)^;=YE=7X*8?=
MA7]+9FP9FA^6?ZPH]__X+#LO<6W[JZ"?S([!^F!C*N?::C/L&]63"ZM?SJV^
M HT
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M(NCDSS@C%:N;9<]]*<6_ %!+ P04 " !J@:5(&Z6"&" $ #;#P #P
M 'AL+W=O A:I7W0S*\9I6T8TKM78:6BB;AJ%P"Z*(#Z_&C\
MGA1RFSP2UZK01O;;M4\Z N@20)=/06]4<$2(C,9##RD:W8#X'5V 0V8UY*&HM&8,2O?
MS%BJL%_*131@1$N:@X K7-)PZ9'X?;@\!LQCZ>&?!5I/3O6*_.^S+HLY9K&D
MVL;D+8HY!+#TO_!C$/_',
ME]=MG4C#''TX@< XEC3^.*YYF6!DH51R3&/&YQ>MD ,1%\< $0#_&(SF;(]\]KU2'[YXK;=)ZB, A\IZ!>J6 SP"YU[(&7].FB=+
M3SS?']6?P[0N_9X:>%3\/ZMMY\*F":JAH0.W[VI\@6F$D+!2W(1?5 W&*G&D
M)$C0K[@R&=8Q?LG_3+3K!#(1R$SXG8;@T2C$?**6EH56(S(]]6>7;1Q<>Q&G
MC%PV$\HP?>P>2I)E!3YXH05F%S$D8$X([-2O6I"EQ8Z F=>O@3W;A2%LGD)%
M%@3LC5R93U33+)5B0*JC]M]M]@8NK8A11J8VY4+7O<^>,Q)%*3Y;H1GFZ#'$
M8383 AOU50LRMSB2*SJY38\6%4:.'GGW77Q;(%X(Q$X@'EN,5UN<8[:W3;8+
MD^U,(%DUF6/N;YLD"Y-D)K!;-9EC_BQ,\-5T<)"5NP0*Y:)OM1^#*3O=LP?B
MINL7GJ4=K> OE573*G02VLRH&\]2" VFB/#.M%J;EV *&)3:;N_-7OK+X0,M
MNLM5G]Z;[ =02P,$% @ :H&E2%:/?:JB 0 L0, !D !X;"]W;W)K
M $'"9D9F95TS)+
MJ93?[EO2[($HFYXU4&]M8>NH1"([!4DO*!,A=X?6^AOW GB/#!G)RIA8%)E0
M*4*VQ18*V%TI9Z-,=:L-V _-W?_62>J6R)'<4EM*4D0#C>Z'-<"58ZT$'A&H
M]TFR4XY=.APY,-#/>)JKJJ0[#
MXZ6(+U\2U7]02P,$% @ :H&E2#)50Q?F @ E L !@ !X;"]W;W)K
M
:K!=NCJ.U#@:/V_>6EUOYT,Z1/8!K\I!=/!3V$X:1P[HP\FF0VT1
M/003V=T])7UX/VNBH/4Q_!QB.U^I.?$XG![(^DJKOU!+ P04 " !J@:5(
MA+0!0O\! >!@ &0 'AL+W=O
\*-*IKAK[